Eastman Chemical Co income statement
In fiscal 2025, Eastman Chemical Co reported revenue of $8.75bn, down 6.7% on the year before and net income of $474m, or $4.10 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.4 | 5.8 | 7.2 | 8.1 | 9.4 | 9.5 | 9.6 | 9.0 | 9.5 | 10.2 | 9.3 | 8.5 | 10.5 | 10.6 | 9.2 | 9.4 | 8.8 | 9.0 |
| Cost of revenue | — | — | — | — | — | — | — | 6.7 | 7.2 | 7.7 | 7.0 | 6.5 | 8.0 | 8.4 | 7.1 | 7.1 | 6.9 | 7.2 |
| Gross profit | 1.0 | 1.5 | 1.6 | 1.8 | 2.8 | 2.2 | 2.6 | 2.4 | 2.4 | 2.5 | 2.2 | 2.0 | 2.5 | 2.1 | 2.1 | 2.3 | 1.8 | 1.9 |
| Research and development | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.2 | 0.3 | 0.3 | 0.2 |
| Selling, general and administrative | 0.4 | 0.4 | 0.5 | 0.6 | 0.6 | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 |
| Operating income | 0.3 | 0.8 | 0.9 | 0.8 | 1.9 | 1.2 | 1.4 | 1.4 | 1.5 | — | — | — | — | — | — | — | — | — |
| Net interest income | −0.1 | −0.1 | −0.1 | −0.1 | −0.2 | −0.2 | −0.3 | −0.3 | −0.2 | −0.2 | −0.2 | −0.2 | −0.2 | −0.2 | −0.2 | −0.2 | −0.2 | −0.2 |
| Income before tax | 0.3 | 0.6 | 0.9 | 0.6 | 1.7 | 1.0 | 1.1 | 1.0 | 1.3 | 1.3 | 0.9 | 0.5 | 1.1 | 1.0 | 1.1 | 1.1 | 0.6 | 0.7 |
| Income tax | 0.1 | 0.2 | 0.3 | 0.2 | 0.5 | 0.2 | 0.3 | 0.2 | −0.1 | 0.2 | 0.1 | 0.0 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.0 |
| Net income | 0.1 | 0.4 | 0.6 | 0.4 | 1.2 | 0.8 | 0.8 | 0.9 | 1.4 | 1.1 | 0.8 | 0.5 | 0.9 | 0.8 | 0.9 | 0.9 | 0.5 | 0.6 |
| Diluted EPS | $0.93 | $2.88 | $4.52 | $2.93 | $7.44 | $4.97 | $5.66 | $5.75 | $9.47 | $7.56 | $5.48 | $3.50 | $6.25 | $6.35 | $7.49 | $7.67 | $4.10 | $5.44 |
| Diluted shares (average) | 147m | 148m | 143m | 149m | 157m | 151m | 150m | 148m | 146m | 143m | 139m | 137m | 137m | 125m | 119m | 118m | 116m | 115m |
| EBITDA | 0.6 | 1.1 | 1.2 | 1.2 | 2.3 | 1.6 | 2.0 | 2.0 | 2.1 | — | — | — | — | — | — | — | — | — |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2,245 | 2,290 | 2,287 | 2,202 | 1,973 | 2,177 | 2,513 | 2,385 |
| Cost of revenue | 1,691 | 1,723 | 1,781 | 1,769 | 1,635 | 1,746 | 1,953 | 1,853 |
| Gross profit | 554 | 567 | 506 | 433 | 338 | 431 | 560 | 532 |
| Research and development | 66 | 67 | 67 | 63 | 58 | 60 | 65 | 63 |
| Selling, general and administrative | 182 | 182 | 157 | 160 | 159 | 178 | 185 | 171 |
| Net interest income | −52 | −49 | −53 | −54 | −52 | −52 | −55 | −56 |
| Income before tax | 297 | 253 | 169 | 134 | 12 | 136 | 256 | 249 |
| Income tax | −34 | 70 | 29 | 65 | −71 | 29 | 72 | −4 |
| Net income | 330 | 182 | 140 | 69 | 83 | 107 | 183 | 252 |
| Diluted EPS | $2.81 | $1.57 | $1.20 | $0.60 | $0.72 | $0.93 | $1.59 | $2.19 |
Compare with peers
Head to head: CE vs EMNEMN vs HUN
More: Diversified Chemicals stocks compared, Materials sector, rankings of US companies